James Parsons
Director/Board Member at DIAMEDICA THERAPEUTICS INC.
Net worth: 239 986 $ as of 2024-04-29
Network origin in James Parsons first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 31 | |
| Public Company | Pharmaceuticals: Major | 26 | |
| Public Company | Biotechnology | 23 | |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Trillium Therapeutics Inc. (TTI), is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders. The Company's therapeutic approaches are aimed at restoring balance to the immune system in conditions associated with aberrant or harmful immune responses, such as autoimmune disease, inflammatory disorders, and cancer. TTI's objective is to create a broad and innovative pipeline of proprietary biologic product opportunities, as part of its overall strategy of building and solidifying its reputation as a premier R & D company. The company's business model is to identify therapeutic candidates that have shown promise in animal models and to rapidly advance these into clinical testing. TTI is concentrating its efforts on preclinical and early clinical drug development, with the primary objective of demonstrating safety and proof-of-principle in man. The company has chosen to establish development partnerships for some of its projects at a preclinical stage, and anticipates advancing several others into clinical development on its own. TTI has five scientific programs at various stages of preclinical testing. Two of its programs focus on the immunoregulatory protein CD200 and its receptor, a third targets the activating Fc receptor Fc RIIa (CD32a) and the final two involve the use of a growth factor in the prevention of necrotizing enterocolitis and the treatment of interstitial cystitis.
13
| Extinct | Miscellaneous Commercial Services | 13 |
| Public Company | Biotechnology | 12 | |
| Public Company | Biotechnology | 12 | |
| Public Company | Pharmaceuticals: Major | 6 | |
| Public Company | Metal Fabrication | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to James Parsons via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Corvita Corp.
 Corvita Corp. Medical SpecialtiesHealth Technology Corvita Corporation is a development stage company engaged primarily in research and development of new medical devices and related biomaterials for treatment of late stage vascular disease. The company is sponsoring two FDA controlled, randomized prospective trials in the US for its peripheral grafts and AV access grafts, both of which are approved for sale in the European Common Market. In addition, Corvita is conducting clinical tests in Europe and plans to begin FDA controlled clinical studies in the US of the Corvita Endoluminal Graft, a new less invasive product for lower cost treatment of vascular trauma, vascular occlusive disease and aneurysmal disease. The majority of the company's activities in FY 96 will be focused on development and testing of Corvita Endoluminal Grafts. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| NYMOX PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
BC Advantage Funds Ltd.
 BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | Investment Managers | Chairman Private Equity Investor | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| TESARO INC | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Corporate Officer/Principal | |
Williams Creek Gold Ltd.
 Williams Creek Gold Ltd. Precious MetalsNon-Energy Minerals Williams Creek Gold Ltd. engages in the exploration of mineral properties. The company was founded on June 19, 1946 and is headquartered in Vancouver, Canada. | Precious Metals | Chairman Chief Executive Officer | |
| University of Glasgow | College/University | Graduate Degree Undergraduate Degree | |
| McGill University | College/University | Doctorate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Toronto | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Western Ontario | College/University | Corporate Officer/Principal Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
| McMaster University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Graduate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Undergraduate Degree | |
| University of Calgary | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Lions Capital Corp.
 Lions Capital Corp. Investment ManagersFinance Lions Capital Corp (Lions Capital) is a fund management and corporate advisory firm founded in 2003. The firm headquartered in Vancouver, Canada. | Investment Managers | Chairman Chief Executive Officer | |
Washington National Opera
 Washington National Opera Movies/EntertainmentConsumer Services Washington National Opera operates as an opera company. The company was founded in 1956 and is headquartered in Washington, DC. | Movies/Entertainment | President Director/Board Member | |
Wi2Wi, Inc.
 Wi2Wi, Inc. Specialty TelecommunicationsCommunications Wi2Wi, Inc. provides advanced microsystems, miniaturized embedded wireless connectivity solutions. Its products include wireless connectivity, timing and frequency control, and antennas and connectors. The company is headquartered in San Jose, CA. | Specialty Telecommunications | Director/Board Member Chairman | |
Interface Biologics, Inc.
 Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Information Technology Services | Director/Board Member Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| PFENEX INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Life Sciences Ontario | Director/Board Member Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Richard Ivey School of Business | College/University | Masters Business Admin Masters Business Admin | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 28 |
| Canada | 18 |
| United Kingdom | 4 |
| Bahamas | 2 |
| France | 2 |
Sectoral
| Consumer Services | 21 |
| Health Technology | 20 |
| Finance | 5 |
| Commercial Services | 4 |
| Non-Energy Minerals | 2 |
Operational
| Director/Board Member | 427 |
| Corporate Officer/Principal | 233 |
| Independent Dir/Board Member | 130 |
| Chairman | 111 |
| President | 90 |
Most connected contacts
| Insiders | |
|---|---|
| Calvin Stiller | 38 |
| Michael R. Sonnenreich | 31 |
| Frank Holler | 29 |
| Hans P. Black | 26 |
| Catherine Mackey | 24 |
| Richard Kuntz | 23 |
| Bernd Seizinger | 23 |
| Leonard Kruimer | 22 |
| Mohammad Azab | 21 |
| Richard Pilnik | 20 |
| Jeffrey Bacha | 20 |
| Luke Beshar | 19 |
| George Adams | 18 |
| Michael Giuffre | 18 |
| Don B. Rix | 18 |
- Stock Market
- Insiders
- James Parsons
- Company connections
